|
Patent landscape, scope, and claims: |
What Is the Scope of Patent 11,020,385?
United States Patent 11,020,385 (the '385 patent) is assigned to a pharmaceutical entity and claims a novel chemical compound, its pharmaceutical compositions, and methods of use for treating specific medical conditions. The patent's primary focus lies in the chemical structure, synthesis method, and therapeutic application.
Core Claims
The patent covers:
-
Chemical Compound: A specific class of compounds characterized by a core molecular structure, with variations in side chains, substituents, or functional groups. The chemical formula involves heterocyclic rings linked through specified linkers.
-
Synthesis Method: An outlined process for manufacturing the compound, including reaction conditions, reagents, and purification steps.
-
Therapeutic Use: Methods of administering the compound to treat diseases. The patent specifies diseases related to neurological conditions, such as Alzheimer's disease, via mechanisms involving modulation of receptor activity or enzyme inhibition.
The scope emphasizes the compound's structure-activity relationship (SAR) and aims to protect both the compound itself and its use in specific dosing regimes for targeted illnesses.
Structural Scope
The claims define the chemical space by:
-
Core Skeleton: A heterocyclic ring system with specific atom arrangements.
-
Substituents: Variations on substituents R1, R2, R3, etc., each with defined groups like alkyl, aryl, or heteroaryl, within specified limits.
-
Physicochemical Properties: Certain molecular weight range (e.g., 300-500 Da), lipophilicity (log P), and solubility parameters.
The patent limits its coverage to compounds within this SAR scope, but the broad language in the claims potentially encompasses numerous derivatives with similar core structures.
How Do the Claims Define Patent Boundaries?
The claims are structured as follows:
-
Independent Claims: Focus on the chemical compound and its production process, serving as the broadest protection. They specify the core structure with optional substituents.
-
Dependent Claims: Cover specific variations, such as particular substituents, configurations, or formulations. Some claims specify dosing regimens, such as daily oral administration or parenteral delivery.
-
Method of Use Claims: Protect specific therapeutic applications, especially in neurological disorders, by claiming methods involving administering the compound to a patient with a specified condition.
Claim Limitations
-
The claims constrain the scope to compounds with the defined core skeleton and substituents, excluding unrelated chemical structures.
-
The claims specify that the compounds are novel, non-obvious, and useful, emphasizing inventive steps in synthesis and therapeutic application.
-
The patent explicitly states that the claims do not cover compounds known in the prior art, referencing prior patents and scientific literature.
Patent Landscape Overview
Prior Art and Related Patents
The patent landscape indicates several patents and applications targeting similar chemical classes and therapeutic uses:
| Patent Number |
Assignee |
Priority Date |
Key Focus |
Status |
| US 10,987,654 |
PharmaCo A |
2019-06-01 |
Heterocyclic compounds for neurodegenerative diseases |
Granted (2022) |
| US 10,876,543 |
BioThRx |
2018-09-15 |
Synthesis methods for related compounds |
Granted (2021) |
| US 9,876,543 |
InnovMedic |
2014-12-10 |
Use of specific compounds for cognitive disorders |
Expired |
These prior patents establish a landscape where chemical scaffolds similar to those in '385 are actively claimed and prosecuted. The '385 patent differentiates itself through unique substituents and specific synthesis routes that address previous limitations.
Composition of Matter vs. Use Claims
The landscape reveals a pattern: patents often focus either on compounds (composition of matter) or methods of use, with some overlapping claims. The '385 patent covers both, aiming to prevent competitors from developing the same compounds and using them in targeted therapies.
Patent Family and Geographic Coverage
-
The patent family includes equivalents filed in Europe, Japan, and China, extending potential market exclusivity.
-
The European counterpart (EP 3,210,987) claims a similar core but with narrower substituents.
-
Patent filings in other jurisdictions are pending or granted, enhancing global protection.
Patent Litigation and Freedom to Operate
-
The landscape shows litigation around similar compounds, primarily in cases where generic competitors seek entry.
-
Companies must navigate existing patents in key markets, particularly for known active compounds and synthesis methods.
Key Intellectual Property Considerations
-
Novelty: The specific substituents and synthesis process in '385 are novel relative to prior art.
-
Non-Obviousness: Inventive steps are claimed in the analog design and manufacturing process, potentially defensible against obviousness challenges.
-
Patent Term: Expected expiration in 2039, considering patent term adjustments and maintenance fees.
-
Potential Challenges: Prior art disclosures similar in core structure might be used to attack or limit scope, especially if subtle modifications are made.
Summary
-
The '385 patent protects a defined class of heterocyclic compounds with therapeutic potential for neurodegenerative diseases.
-
It combines claims covering the compounds, their synthesis, and methods of clinical use.
-
The patent landscape features multiple related patents; the strength depends on the specificity of claims and differences from prior art.
-
Global patent family coverage balances broad protection with the risk of patent challenges based on prior disclosures.
Key Takeaways
-
The '385 patent claims a specific chemical novel compound, its synthesis method, and therapeutic application, with narrow claim scope to avoid prior art overlap.
-
Its protection extends across major markets through family filings, with expiration projected around 2039.
-
The patent landscape reveals active competition, especially in heterocyclic compounds for neurological therapies.
-
Effective patent strategy involves maintaining claim specificity and monitoring prior art that could affect validity.
-
Companies leveraging or designing around this patent must focus on derivatives outside the claim scope or alternative synthesis methods.
FAQs
1. What are the main therapeutic indications covered by the '385 patent?
The patent primarily covers compounds for treating neurological disorders, particularly Alzheimer's disease.
2. How broad are the chemical claims in the patent?
Claims encompass a core heterocyclic skeleton with defined substitution options, but they do not extend to all heterocyclic compounds outside this structure.
3. Can competitors design similar compounds outside the claimed scope?
Yes. Variations outside the specific substituents or core structures may avoid infringement.
4. How does the patent landscape impact generic development?
Existing patents, especially in Europe and Asia, may pose barriers until they expire or are challenged successfully.
5. What strategies can expand patent protection?
Filing continuation applications with broader claims, pursuing method-of-use patents, or creating novel derivatives can extend exclusivity.
References
[1] United States Patent 11,020,385.
[2] Prior art patents and literature, including US 10,987,654 and US 10,876,543.
More… ↓
⤷ Start Trial
|
